IT1391663B1 - Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono - Google Patents
Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengonoInfo
- Publication number
- IT1391663B1 IT1391663B1 ITMI2008A001982A ITMI20081982A IT1391663B1 IT 1391663 B1 IT1391663 B1 IT 1391663B1 IT MI2008A001982 A ITMI2008A001982 A IT MI2008A001982A IT MI20081982 A ITMI20081982 A IT MI20081982A IT 1391663 B1 IT1391663 B1 IT 1391663B1
- Authority
- IT
- Italy
- Prior art keywords
- 5alphe
- reductase
- inhibit
- enzyme
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2008A001982A IT1391663B1 (it) | 2008-11-10 | 2008-11-10 | Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono |
US13/128,394 US9668984B2 (en) | 2008-11-10 | 2009-11-10 | Use of compounds to inhibit 5 α-reductase enzyme activity, and pharmaceutical and cosmetic compostions containing them |
PCT/EP2009/064881 WO2010052329A1 (en) | 2008-11-10 | 2009-11-10 | The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them |
EP09764757.2A EP2373302B1 (en) | 2008-11-10 | 2009-11-10 | THE USE OF COMPOUNDS TO INHIBIT 5alpha-REDUCTASE ENZYME ACTIVITY, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM |
JP2011535128A JP5784499B2 (ja) | 2008-11-10 | 2009-11-10 | 5α−レダクターゼ酵素活性を阻害するための化合物の使用、並びにそれを含有する医薬及び化粧品組成物 |
CA2743216A CA2743216C (en) | 2008-11-10 | 2009-11-10 | The use of compounds to inhibit 5a-reductase enzyme activity, and pharmaceutical and cosmetic compositions containing them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2008A001982A IT1391663B1 (it) | 2008-11-10 | 2008-11-10 | Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono |
Publications (2)
Publication Number | Publication Date |
---|---|
ITMI20081982A1 ITMI20081982A1 (it) | 2010-05-11 |
IT1391663B1 true IT1391663B1 (it) | 2012-01-17 |
Family
ID=41020757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI2008A001982A IT1391663B1 (it) | 2008-11-10 | 2008-11-10 | Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono |
Country Status (6)
Country | Link |
---|---|
US (1) | US9668984B2 (it) |
EP (1) | EP2373302B1 (it) |
JP (1) | JP5784499B2 (it) |
CA (1) | CA2743216C (it) |
IT (1) | IT1391663B1 (it) |
WO (1) | WO2010052329A1 (it) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1401289B1 (it) * | 2010-04-22 | 2013-07-18 | Giuliani Spa | Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono |
EP2407163A1 (en) | 2010-07-16 | 2012-01-18 | Giuliani S.p.A. | Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them |
ITMI20131475A1 (it) | 2013-09-06 | 2015-03-07 | Giuliani Spa | Composizioni utili nella prevenzione e terapia dei tumori della pelle |
JP6200267B2 (ja) * | 2013-10-07 | 2017-09-20 | カイゲンファーマ株式会社 | 5αレダクターゼ阻害剤 |
AU2016381976B2 (en) | 2015-12-31 | 2019-12-19 | Colgate-Palmolive Company | Cleansing compositions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8506027D0 (en) | 1985-03-08 | 1985-04-11 | Efamol Ltd | Pharmaceutical & dietary compositions |
JP2894805B2 (ja) * | 1990-07-02 | 1999-05-24 | ライオン株式会社 | 液体頭髪化粧料 |
JPH11269056A (ja) * | 1998-03-24 | 1999-10-05 | Kyowa Hakko Kogyo Co Ltd | 化粧料 |
FR2803749B1 (fr) | 2000-01-18 | 2006-09-22 | Pharmascience Lab | Utilisation d'au moins un ester gras pour la preparation d'une composition destinee a inhiber l'activite de la 5 alpha-reductase, en pharmacie notamment en dermatologie, en cosmetique et en tant qu'additif alimentaire |
IL152904A0 (en) * | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
ITMI20020960A1 (it) * | 2002-05-07 | 2003-11-07 | Univ Degli Studi Milano | Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale |
JP2008088127A (ja) | 2006-10-04 | 2008-04-17 | Shiseido Co Ltd | ニキビ肌用皮膚外用組成物 |
JP5122147B2 (ja) * | 2007-01-16 | 2013-01-16 | アサヒグループホールディングス株式会社 | 抗酸化作用を有する2−(2−メチルプロパノイル)フロログルシノール−1,5−ジ−O−β−D−グルコピラノシド |
-
2008
- 2008-11-10 IT ITMI2008A001982A patent/IT1391663B1/it active
-
2009
- 2009-11-10 JP JP2011535128A patent/JP5784499B2/ja active Active
- 2009-11-10 EP EP09764757.2A patent/EP2373302B1/en active Active
- 2009-11-10 US US13/128,394 patent/US9668984B2/en active Active
- 2009-11-10 WO PCT/EP2009/064881 patent/WO2010052329A1/en active Application Filing
- 2009-11-10 CA CA2743216A patent/CA2743216C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2373302A1 (en) | 2011-10-12 |
JP2012508214A (ja) | 2012-04-05 |
CA2743216A1 (en) | 2010-05-14 |
CA2743216C (en) | 2017-10-17 |
US20110218245A1 (en) | 2011-09-08 |
US9668984B2 (en) | 2017-06-06 |
EP2373302B1 (en) | 2017-09-13 |
WO2010052329A1 (en) | 2010-05-14 |
ITMI20081982A1 (it) | 2010-05-11 |
JP5784499B2 (ja) | 2015-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013014231A2 (pt) | composição de higiene pessoal e uso da composição de higiene pessoal | |
SMT201400055B (it) | Composti di tioacetato, composizioni e metodi d'uso | |
GB2431876B (en) | Use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions | |
SMT201400114B (it) | Derivati di 2-arilimidazolo come inibitori dell'enzima pde10a | |
BR112013004914A2 (pt) | "composições de pele e métodos de uso das mesmas". | |
BR112012002982A2 (pt) | uso de cosméticos de extratos de levedura salientados modificados e composições relacionadas. | |
HK1142536A1 (en) | Gel useful for the delivery of cosmetic active ingredients | |
BRPI1010761A2 (pt) | "composições semi-sólidas e produtos farmacêuticos" | |
BRPI0920355A2 (pt) | composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina | |
FR2951946B1 (fr) | Utilisation d'un hydrolysat peptidique de levure en tant qu'agent actif pour renforcer le cheveu | |
SMT201400158B (it) | Derivati eteroaromatici di fenilimidazolo come inibitori dell'enzima pde10a | |
ZA201301684B (en) | Compositions comprising at least one compound containing a carbamoyl sulfonate group and use of the same as tanning agents | |
SMT201300080B (it) | Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah | |
FR2916633B1 (fr) | Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1 | |
BR112012025270A2 (pt) | "composição de cuidados pessoais" | |
IT1397247B1 (it) | Nuovi agenti regolatori dell'attivita' citochinica | |
ITFI20050041A1 (it) | Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono | |
IT1391663B1 (it) | Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono | |
ITTO20110205A1 (it) | Composizione cosmetica oppure dermatologica comprendente l'associazione di un miele e di un peptide. | |
IT1401218B1 (it) | Composizione ad attivita' bio-rigenerativa, riparativa ed eutrofizzante. | |
FR2997299B1 (fr) | Association d'extraits de plantes, ingredient actif cosmetique et composition les contenant, et utilisation topique cosmetique | |
ITMI20050730A1 (it) | Preparazione di composizioni con elevata attivita'insetticida | |
FR2958847B1 (fr) | Utilisation d'un hydrolysat peptidique de pois en tant qu'agent actif hydratant | |
ITRM20060346A1 (it) | Composizioni ad attivita' antigerminativa processi per ottenere dette composizioni e loro impiego | |
FR2962902B1 (fr) | Utilisation cosmetique d'une eau de source et compositions cosmetiques ou dermatologiques la contenant |